SRC‐1 reprograms TAMs via STAT1‐mediated MMP12 activation to facilitate PNI. Targeting SRC‐1 disrupts this axis and presents a novel therapeutic strategy against PNI in pancreatic cancer. The gene discussed is STAT1; the disease is familial pancreatic carcinoma.